The present article aims to assess the multitude of AR signaling aspects, encompassing the biological structure of AR, current AR-targeted therapies, mechanisms driving resistance to AR, and AR crosstalk with other pathways, in an attempt to provide a comprehensive and unique document for the PCa research community. The gene discussed is AR; the disease is posterior cortical atrophy.